Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BLACKROCK Municipal Income TRUST V.BFK.P


Primary Symbol: BFK

BlackRock Municipal Income Trust (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is to provide current income exempt from federal income taxes. Under normal market conditions, the Fund invests at least 80% of its managed assets in investments the income from which is exempt from federal income tax (except that the interest may be subject to the alternative minimum tax). The Fund may invest directly in securities or synthetically through the use of derivatives. The Fund's investment policies provide that it invests at least 80% of its total assets in investment grade quality municipal obligations issued by or on behalf of states, territories and possessions of the United States and their political subdivisions, agencies or instrumentalities, each of which pays interest that, in the opinion of bond counsel to the issuer, is excludable from gross income for federal income tax purposes. Its investment adviser is BlackRock Advisors, LLC.


NYSE:BFK - Post by User

Post by Ghostinthedarkon Oct 29, 2021 8:02am
98 Views
Post# 34062199

Financials--net losss ($68million) Total revenue ($38,760)

Financials--net losss ($68million) Total revenue ($38,760)

Financial Update

In 000’s For the three months ended For the twelve months ended
  Income Statement Snapshot July 31,
 2021
  April 30,
 2021
  July 31,
2020 
  July 31,
 2021
  July 31,
 2020
 
                    $                   $   $   $   $  
Revenue from sale of goods 53,022   33,082   36,140   173,081   110,149  
Excise taxes (14,365 ) (10,482 ) (9,082 ) (49,583 ) (29,598 )
Net revenue from sale of goods 38,657   22,600   27,058   123,498   80,551  
Ancillary revenue 103   60   87   271   233  
Total revenue 38,760   22,660   27,145   123,769   80,784  
                     
Gross profit before adjustments2 7,988   5,006   8,104   34,175   26,953  
Gross profit/(loss) before fair value adjustments 1,499   4,379   (36,012 ) 29,066   (46,421 )
Gross profit/(loss)2 3,234   8,816   (34,690 ) 48,798   (57,975 )
                     
Operating expenses (63,116 ) (24,906 ) (71,509 ) (134,293 ) (418,576 )
Loss from operations (59,882 ) (16,090 ) (106,199 ) (85,495 ) (476,551 )
Other expenses and losses (9,630 ) (4,621 ) (63,333 ) (29,664 ) (75,961 )
Loss and comprehensive loss before tax (69,512 ) (20,711 ) (169,532 ) (115,159 ) (552,512 )
                     
Current and deferred tax recovery 397       397   6,023  
Other comprehensive income 1,156   3     1,152    
Total Net loss and comprehensive loss (67,959 ) (20,708 ) (169,532 ) (113,610 ) (546,489 )

Advertisement

 
STORY CONTINUES BELOW
 

Article content

1 The Company has adjusted the presentation of gross profit before fair value adjustments by removing inventory and biological asset write offs and impairment losses.
2 See section ‘Cost of Sales, Excise Taxes and Fair Value Adjustments’ for reconciliation of gross profits

Operating Expenses

In 000’s For the three months ended For the years ended
  July 31,
2021
April 30,
2021
  July 31,
2020
  July 31,
2021
July 31,
2020
  $ $   $   $ $
Selling, general and administration1 19,160 11,178   12,436   54,543 52,793
Marketing and promotion 3,665 2,452   2,375   10,348 12,474
Share-based compensation 827 2,715   4,373   11,731 25,790
Research and development 934 730   677   3,835 4,639
Depreciation of property, plant and equipment 1,728 1,612   1,179   6,097 6,072
Amortization of intangible assets 1,002 371   249   2,050 3,939
Restructuring costs 1,562 336   (79 ) 3,283 4,767
Impairment of property, plant and equipment 19,350 16   46,414   20,230 79,418
Impairment of intangible assets   2,000   108,189
Impairment of goodwill     111,877
Realization of onerous contract   1,763   4,763
Disposal of long-lived assets   122   1,294 3,855
Loss/(gain) on disposal of property, plant and equipment 19 (19 )   64
Acquisition transaction costs 14,869 1,871     17,174
Health Canada Recovery Fee’s1 3,644     3,644
Total 63,116 24,906   71,509   134,293 418,576
1 The Company has adjusted the presentation of the Selling, General and Administrative expenses to breakdown the Health Canada Recovery Fee’s for ease of user review and identification. This presentation differs from that of the Company’s interim financial statement for the year ended July 31, 2021.  

Advertisement

 
STORY CONTINUES BELOW
 

Article content

Other Matters

Gross margins

Quarter-over-quarter, the Company’s total gross margin declined to 20% from 22% in Q3’21. Net adult-use revenue (exclusive of beverages) gross margin declined to 12% from 28% due to; increases to sales in higher excise tax burdened markets, decreases to average selling prices, and the crystallization of fair value adjustments upon the business acquisition of Zenabis.

Normalizing for the impact of the crystallization, the Company’s total gross margin would improve to 26% in Q4’21. Strong margined international sales grew significantly in period to net revenues of $6.8 million and a gross margin contribution of 65%. Wholesales were also impacted by the crystallization of fair value adjustments on the purchase price accounting of Zenabis, normalized for this, margins would otherwise have been 35% versus reported gross margin of (65%).

Going Concern & the Senior Secured Convertible Note

The Company acknowledges the ongoing concern with its senior secured convertible notes issued on May 27, 2021. The Company has maintained a positive relationship with the holder, with the holder having negotiated and agreed to two amendments favorable to the Company.  While there exists a risk that significant cash outflows may be required over the next twelve months under the terms of the Senior Secured Convertible Note, the Company has been working with the Holder to renegotiate the terms of the Senior Secured Convertible Note. 

<< Previous
Bullboard Posts
Next >>